Dr Dan Milner appointed Executive Director of the ATOM Coalition

UICC is pleased to announce that Dr Dan Milner will lead the Secretariat of the Access to Oncology Medicines (ATOM) Coalition in the new role of Executive Director, beginning this month. 

"Dan has been a long-time and trusted collaborator and friend of UICC. Thanks to the support from the American Society of Clinical Pathology (ASCP), one of the founding ATOM Coalition partners, Dan will guide the organisation in these critical months as we work to grow the ATOM Coalition, encourage partner engagement, and prepare to support and work with partners in countries to strengthen their capacity."
– Cary Adams, CEO of UICC

Dan will provide technical expertise and lead the organisation's strategy, building on the foundation that has been laid since the launch in May 2022 to focus attention on the availability of medicines availability and pathology needs in low- and lower-middle income countries. 

Dan previously served as the Chief Medical Officer of ASCP and has proven leadership in global health initiatives and on-the-ground experience, most notably in Africa and Haiti,  which will help the ATOM Coalition in meeting its ambition of strengthening diagnostic services and timely access to cancer medicines where they are most needed. 

Dan has already made invaluable contributions to the early success of the ATOM Coalition, playing a key role putting forward recommendations for the priority list of medicines as part of the Medicines Expert Advisory Group, and is the current chair of the Diagnostic Expert Advisory Group.